Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb 14:16:857408.
doi: 10.3389/fnins.2022.857408. eCollection 2022.

Editorial: Brain Cancers: New Perspectives and Therapies

Elisa Roda  1 , Maria Grazia Bottone  2
Affiliations
Editorial

Editorial: Brain Cancers: New Perspectives and Therapies

Elisa Roda et al. Front Neurosci. .
No abstract available

Keywords: brain tumors; chemotherapeutic medicines; glioblastoma; novel therapies; tumor resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Brain Cancers: New Perspectives and Therapies

References

    1. Aldape K., Brindle K. M., Chesler L., Chopra R., Gajjar A., Gilbert M. R., et al. . (2019). Challenges to curing primary brain tumours. Nat. Rev. Clin. Oncol. 16, 509–520. 10.1038/s41571-019-0177-5 - DOI - PMC - PubMed
    1. Birzu C., French P., Caccese M., Cerretti G., Idbaih A., Zagonel V., et al. . (2021). Recurrent glioblastoma: from molecular landscape to new treatment perspectives. Cancers 13:47. 10.3390/cancers13010047 - DOI - PMC - PubMed
    1. Brahm C. G., van Linde M. E. H, Enting R. H., Schuur M., Otten R. H. J., et al. . (2020). The current status of immune checkpoint inhibitors in neuro-oncology: a systematic review. Cancers 12:586. 10.3390/cancers12030586 - DOI - PMC - PubMed
    1. Chen X., Zhang M., Gan H., Wang H., Lee J. H., Fang D., et al. . (2018). A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma. Nat. Commun. 9:2949. 10.1038/s41467-018-05373-4 - DOI - PMC - PubMed
    1. Chovanec M., Abu Zaid M., Hanna N., El-Kouri N., Einhorn L. H., Albany C. (2017). Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann.Oncol. 28, 2670–2679. 10.1093/annonc/mdx360 - DOI - PMC - PubMed

Publication types

LinkOut - more resources